Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors
Clinical trial NCT04234113 · TERMINATED
Trial details
- NCT number
- NCT04234113
- Sponsor
- SOTIO Biotech AG
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-13
- Primary completion
- 2024-08-31
- Enrollment
- 115
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.